A Selective Reduction of Osteosarcoma by Mitochondrial Apoptosis Using Hydroxyapatite Nanoparticles

BACKGROUND: In recent years, using hydroxyapatite nanoparticles (HANPs) for tumor therapy attracted increasing attention because HANPs were found to selectively suppress the growth of tumor cells but exhibit ignorable toxicity to normal cells. PURPOSE: This study aimed to investigate the capacities...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hongfeng, Liu, Shuo, Chen, Siyu, Hua, Yuchen, Li, Xiangfeng, Zeng, Qin, Zhou, Yong, Yang, Xiao, Zhu, Xiangdong, Tu, Chongqi, Zhang, Xingdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423115/
https://www.ncbi.nlm.nih.gov/pubmed/36046839
http://dx.doi.org/10.2147/IJN.S375950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423115/
https://www.ncbi.nlm.nih.gov/pubmed/36046839
http://dx.doi.org/10.2147/IJN.S375950

Ejemplares similares